Pharma Integrates 2022 Track 2

TECHNOLOGY

How can we use technology to improve health outcomes, improve sustainability and create robust supply chains?

Welcome and opening remarks

Susan Rienow, Country President UK, Pfizer & Vice President ABPI

Fireside Chat

TIM FERRIS | National Director of Transformation | NHS England and NHS Improvement

Interviewed by

JENNY OUSBEY | Chief Executive Officer & Founder | Ovid Health

Fireside Chat

LORD DAVID PRIOR | Deputy Chairman UK and Global Senior Advisor | Lazard

Interviewed by

TAMSIN BERRY | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners

Formulating the future

There is a pressure to speed up time to market, but what can drug development scientists do to speed up this important stage?

FACILITATED BY

Maureen Wedderburn | Non Executive Chair | Medicines Manufacturing Innovation Centre

PANELLISTS

Claire Thompson | Chief Executive Officer | Agility Life Sciences
Christopher Morton | Chief Executive Officer | ELEM Biotech
David O’Connell | Director of Scientific Affairs | PCI Pharma Services
Dolly Jacob | Director, Integrated Development Services, Early Development | Quotient Sciences
Anke Domdey | Director Pharmaceutical Development | Nanoform

Go Green!

The UK has committed to reduce its greenhouse-gas emissions to net zero by 2050. What is the Industry doing to support this?

FACILITATED BY

Christophe Le Ret | Global Marketing Director | Umicore

PANELLISTS

Mark Cassidy | CEO & President | Ajinomoto Bio-Pharma Services Europe
Christian Jones | Chief Commercial Officer | Nanoform
Robert Williams | Procurement Director | AstraZeneca
Roland Brown | Director, Analytical R&D | Pfizer
Jack Eastwood | Chief Operating Officer | Protium

Detect. Inspect. HealthTech.

Innovations around Covid-19 changed the MedTech landscape, but are those learnings being adopted for other conditions? How are drug devices converging with digital?

FACILITATED BY

Phil Carvil | HealthTec Cluster Manager | UKRI Science and Technology Facilities Council

PANELLISTS

Charlotte Lee-Sinclair | Principal consultant and founder | Third Culture Ventures
John Drakenberg | Co-founder & CEO | Alex Therapeutics
Rahul Kapoor | Director of Health Tech | CPI
Neil Tween | Chief Financial Officer | Owlstone Medical

Signed Sealed Delivered

How is technology enabling an efficient and robust supply chain?
Consumers, treatments and health systems are changing – can truly disruptive innovation in healthcare supply chains meet these needs?
How do corporates and start-ups collaborate to effect that change at pace?

FACILITATED BY

Reza Khalesi | Global Head HLS Consulting | Atos Consulting

PANELLISTS

Stefan Kulik | Managing Director | Royal Mail Health
Santosh Sahu | CEO and Founder | Charac
Jagjit Singh Srai | Director of Research | University of Cambridge
Lee Fosbrook | Partner | Atos Consulting

Artificial Intelligence – hype, hope or happening?

AI is being applied to drug discovery, development, diagnosis and supply chains. How successful has it been so far? What does the future hold?

FACILITATED BY

Ele Harwich | Director | Newmarket Strategy

PANELLISTS

Raminderpal Singh | Chief Executive Officer and co-Founder | Incubate.bio Ltd
Beth Fordham | Operations Director | White Swan
Ajay Mistry | Co-Founder & Chief Executive Officer, | Oppilotech
Steve Gardner | Chief Executive Officer | PrecisionLife Ltd
Jessica Morley | Director of Policy | Bennett Institute for Applied Data Science, University of Oxford